Project Grant 10SIHDC001

The National Institute of Allergy and Infectious Diseases awarded Albert Einstein College of Medicine $252,000 on August 3, 2026, to develop community-led, accountable, and ethical recommendations for artificial intelligence use in HIV implementation science research under the Allergy and Infectious Diseases Research program (CFDA 93.855). The recipient will employ community-engaged methods to co-develop CARE-AI (Community-led Accountable Responsible and Ethical recommendations for AI)...

Federal Grant Award Summary The Health Resources and Services Administration's HIV/AIDS Bureau awarded $150,000 under the HIV-Related Training and Technical Assistance program (CFDA 93.145) to Fresno Community Hospital & Medical Center for implementation of an HIV care innovation initiative. The award, effective September 1, 2025, through August 31, 2026, funds the deployment of a dedicated eligibility advocate within the Community Special Services (CSS) clinic to streamline Ryan White...

The Centers for Disease Control and Prevention awarded a $1.185 million cooperative agreement to Health Research, Inc. on September 30, 2025, under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance program (CFDA 93.944) to conduct a Medical Monitoring Project. Health Research, Inc., operating as Health Research At The Aids Institute and headquartered in Menands, New York, is a tax-exempt nonprofit providing HIV/AIDS care, prevention, and public...

The Department of Health and Human Services Health Resources and Services Administration awarded the University of Missouri-Kansas City $1,289,979 under the Special Projects of National Significance (SPNS) program on September 1, 2026, to serve as the national evaluation provider for HRSA's 2026–2029 SPNS initiative on strategies to link, engage, and retain men with HIV in care. The recipient will conduct a rigorous, practical, multi-site implementation science evaluation of intervention...

The Health Resources and Services Administration HIV/AIDS Bureau awarded Emory University $3.24 million on September 1, 2026, under the Special Projects of National Significance program (CFDA 93.928) to serve as implementation technical assistance provider for the REACH Men initiative. REACH Men will deliver intensive technical assistance, organizational development support, implementation coaching, continuous quality improvement, and peer learning to eight Ryan White HIV/AIDS Program-funded...

Federal Grant Award Summary UT Southwestern Medical Center received a $150,000 project grant from the Health Resources and Services Administration's HIV/AIDS Bureau under the HIV-Related Training and Technical Assistance program (CFDA 93.145) for the period of September 1, 2025, through August 31, 2026. Under this award, UT Southwestern's Dallas Family Access Network (DFAN) Engage Initiative, led by Dr. Jeremy Chow, will deliver community-based outreach and capacity-building services to...

The Department of Housing and Urban Development Assistant Secretary for Community Planning and Development awarded the Aids Foundation of Chicago $2,639,016 on May 1, 2026, under the Continuum of Care Program (CFDA 14.267), a Project Grant supporting housing and supportive services for individuals and families experiencing homelessness. The award funds eligible activities across the COC program's five components: permanent housing (including permanent supportive housing for persons with...

The Department of Health and Human Services Health Resources and Services Administration awarded the Louisiana Department of Health $5,252,935 on April 1, 2026, under the HIV Care Formula Grants program (CFDA 93.917) to provide ADAP Shortfall Relief through March 31, 2027. The award funds health insurance access, coverage, and maintenance for people with HIV in Louisiana, as well as medication access for the uninsured. The funding sustains the Louisiana AIDS Drug Assistance Program, locally...

Federal Grant Award Summary New York Blood Center, Inc. received a $485,131 Project Grant from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242) effective September 22, 2025, with completion targeted for September 21, 2027. The award funds research investigating the influence of social networks on HIV (Human Immunodeficiency Virus) testing and PrEP (Pre-Exposure Prophylaxis) care utilization among young Latin American gay, bisexual, and other...

The National Institute of Allergy and Infectious Diseases awarded Boston Medical Center Corporation $1,271,538 on June 18, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to evaluate respondent-driven sampling as a strategy for tuberculosis case finding among people who use drugs and their household contacts in Kampala, Uganda. The study, titled TACTIC (Tuberculosis Active Case Tracking via Interpersonal Connections), compares the effectiveness and reach of...